Product Code: ETC12999860 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Polycystic Kidney Disease Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Polycystic Kidney Disease Market - Industry Life Cycle |
3.4 Vietnam Polycystic Kidney Disease Market - Porter's Five Forces |
3.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.9 Vietnam Polycystic Kidney Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Vietnam Polycystic Kidney Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about polycystic kidney disease in Vietnam |
4.2.2 Growing prevalence of polycystic kidney disease patients in the country |
4.2.3 Improving healthcare infrastructure and access to treatment options in Vietnam |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals for polycystic kidney disease management |
4.3.2 High costs associated with treatment and medications for polycystic kidney disease in Vietnam |
5 Vietnam Polycystic Kidney Disease Market Trends |
6 Vietnam Polycystic Kidney Disease Market, By Types |
6.1 Vietnam Polycystic Kidney Disease Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Vasopressin Receptor Antagonists, 2021 - 2031F |
6.1.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By mTOR Inhibitors, 2021 - 2031F |
6.1.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By ACE Inhibitors, 2021 - 2031F |
6.1.6 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By ARBs, 2021 - 2031F |
6.2 Vietnam Polycystic Kidney Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Dialysis, 2021 - 2031F |
6.2.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Kidney Transplant, 2021 - 2031F |
6.2.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Lifestyle Modifications, 2021 - 2031F |
6.2.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Supportive Therapy, 2021 - 2031F |
6.3 Vietnam Polycystic Kidney Disease Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Home Care, 2021 - 2031F |
6.4 Vietnam Polycystic Kidney Disease Market, By Diagnosis Type |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Imaging Tests, 2021 - 2031F |
6.4.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.4.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Biopsy, 2021 - 2031F |
6.4.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Urine Tests, 2021 - 2031F |
6.5 Vietnam Polycystic Kidney Disease Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5.3 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.4 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.5.5 Vietnam Polycystic Kidney Disease Market Revenues & Volume, By Others, 2021 - 2031F |
7 Vietnam Polycystic Kidney Disease Market Import-Export Trade Statistics |
7.1 Vietnam Polycystic Kidney Disease Market Export to Major Countries |
7.2 Vietnam Polycystic Kidney Disease Market Imports from Major Countries |
8 Vietnam Polycystic Kidney Disease Market Key Performance Indicators |
8.1 Number of patients diagnosed with polycystic kidney disease annually |
8.2 Percentage of polycystic kidney disease patients receiving appropriate treatment |
8.3 Average waiting time for patients to access specialized care for polycystic kidney disease |
9 Vietnam Polycystic Kidney Disease Market - Opportunity Assessment |
9.1 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.5 Vietnam Polycystic Kidney Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Vietnam Polycystic Kidney Disease Market - Competitive Landscape |
10.1 Vietnam Polycystic Kidney Disease Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Polycystic Kidney Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |